Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Heikki Kouru"'
Autor:
Anna Yliniemi, Kaarin Makikallio, Teemu Korpimaki, Heikki Kouru, Jaana Marttala, Markku Ryynanen
Publikováno v:
Clinical Medicine Insights: Reproductive Health, Vol 2015, Iss 9, Pp 13-20 (2015)
Externí odkaz:
https://doaj.org/article/25be1004669a4f0ab24fcf37a780c1f8
Autor:
Markku Ryynanen, Heikki Kouru, Mikko Sairanen, Julia Alanen, Teemu Korpimaki, Mika Gissler, Jaana Nevalainen, Heidi Appelblom
Publikováno v:
Archives of Gynecology and Obstetrics
Purpose To evaluate the performance of first trimester maternal serum glycosylated (Sambucus nigra lectin-reactive) fibronectin in prediction of gestational diabetes mellitus (GDM). Methods In this case–control study, first trimester maternal serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d324b2f407193e8dbbd8430bf1b339d7
http://urn.fi/urn:nbn:fi-fe2020110288990
http://urn.fi/urn:nbn:fi-fe2020110288990
Autor:
Mikko Sairanen, Markku Leskinen, Jaana Nevalainen, Heikki Kouru, Mika Gissler, Markku Ryynanen, Julia Alanen, Teemu Korpimaki
Publikováno v:
The Journal of Maternal-Fetal & Neonatal Medicine. 32:3272-3277
Objective: To evaluate the performance of first trimester biochemical markers, pregnancy-associated plasma protein-A (PAPP-A), free beta human chorionic gonadotropin (fβ-hCG), and nuchal translucency (NT) in detection of severe congenital heart defe
Publikováno v:
Metabolism. 75:6-15
To develop a predictive risk model for early-onset pre-eclampsia (EO-PE) using maternal characteristics, combined screening markers, previously reported biomarkers for PE and mean arterial pressure (MAP).This retrospective study was conducted at Oulu
Publikováno v:
Clinical Medicine Insights: Reproductive Health, Vol 2015, Iss 9, Pp 13-20 (2015)
Clinical Medicine Insights. Reproductive Health
Clinical Medicine Insights: Reproductive Health, Vol 9 (2015)
Clinical Medicine Insights. Reproductive Health
Clinical Medicine Insights: Reproductive Health, Vol 9 (2015)
Objective To evaluate the efficacy of first-trimester markers–-pregnancy-associated plasma protein A (PAPPA), free human chorionic gonadotropin β (fhCGβ), alpha-fetoprotein (AFP), placental growth factor (PlGF), and soluble tumor necrosis factor
Autor:
Jaana Marttala, Sanni Kopman, Heikki Kouru, Teemu Korpimaki, Mona-Marika Nurkkala, Anna Yliniemi, Markku Ryynanen
Publikováno v:
Metabolism. 64:521-526
In a retrospective case-control study, we examined the levels of placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in first-trimester maternal serum samples as well as maternal characteristics to predict
Autor:
Mikko Sairanen, Jaana Nevalainen, Mika Gissler, Markku Leskinen, Markku Ryynanen, Teemu Korpimaki, Julia Alanen, Heikki Kouru
Publikováno v:
The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 32(9)
To evaluate the performance of first-trimester measurement of fetal nuchal translucency (NT) in the detection of severe congenital heart defects (CHDs).During the study period of 1 January 2008 - 31 December 2011, NT was measured in 31,144 women as a
Autor:
Arianne N Sweeting, Mikko Sairanen, Jon Hyett, Jencia Wong, Paul F. Williams, Glynis P. Ross, Heidi Appelblom, Heikki Kouru
Publikováno v:
Fetal diagnosis and therapy. 45(2)
Introduction: Accurate early risk prediction for gestational diabetes mellitus (GDM) would target intervention and prevention in women at the highest risk. We evaluated novel biomarker predictors to develop a first-trimester risk prediction model in
Autor:
Jencia Wong, Paul F. Williams, Arianne N Sweeting, Heikki Kouru, Mikko Sairanen, Heidi Appelblom, Jon Hyett, Glynis P. Ross
We examined whether first trimester aneuploidy and pre-eclampsia screening markers predict gestational diabetes mellitus (GDM) in a large multi-ethnic cohort and the influence of local population characteristics on markers.Clinical and first trimeste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5356f04b511ad0fec0c28e126d09345e
Autor:
F. Figueras, Mikko Sairanen, Stefania Triunfo, Jezid Miranda, E. Gratacós, M. Parra-Saavedra, Fatima Crispi, Francesca Crovetto, Heikki Kouru, Merida Rodriguez-Lopez
Publikováno v:
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
OBJECTIVES: To compare the performance of third-trimester screening, based on estimated fetal weight centile (EFWc) vs a combined model including maternal baseline characteristics, fetoplacental ultrasound and maternal biochemical markers, for the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b7f1d6a25014a6c77b831714c920a9
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10635
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10635